The geographical distribution of dengue fever is expanding globally, driven by environmental shifts and systemic healthcare deficiencies, while comorbid health conditions significantly exacerbate patient outcomes.

在環境變遷與醫療體系不足的推動下，登革熱的地理分佈正全球擴張，而共病健康狀況顯著地加劇了患者的預後結果。

The proliferation of arboviral diseases is attributed to a confluence of climate pressures, rapid urbanization, and inadequate surveillance infrastructure. Statistical data indicate a substantial escalation in reported cases, rising from approximately 500,000 in 2000 to 14.6 million in 2024. This upward trajectory is compounded by the asymptomatic nature of many infections, which facilitates under-reporting and obscures the actual disease burden. In regions such as Africa and Latin America, the response is characterized by fragmentation due to fiscal constraints and shifting institutional priorities.

節肢動物傳播病毒疾病的擴散歸因於氣候壓力、快速城市化以及監控基礎設施不足的共同影響。統計數據顯示，報告病例大幅增加，從 2000 年的約 50 萬例上升至 2024 年的 1,460 萬例。由於許多感染屬於無症狀性質，導致漏報現象嚴重，掩蓋了實際的疾病負擔，使此上升趨勢更為複雜。在非洲和拉丁美洲等地區，由於財政限制和機構優先事項的轉移，其應對措施呈現碎片化特徵。

Clinical challenges are intensified by the symptomatic similarity between dengue and other febrile illnesses, such as malaria, which frequently results in diagnostic errors. The critical window for intervention is narrow; failure to achieve early detection often leads to rapid physiological deterioration. Furthermore, the presence of chronic comorbidities significantly elevates the risk of severe dengue. According to Dr. Anil Vardani, patients with diabetes exhibit a 2.5-fold increase in the risk of dengue hemorrhagic fever, a risk that escalates eightfold when cardiovascular disease is also present. Hypertension and obesity similarly correlate with higher incidences of plasma leakage and organ dysfunction, while chronic kidney disease is associated with a threefold increase in mortality rates.

臨床挑戰因登革熱與瘧疾等其他發燒疾病的症狀相似而加劇，這經常導致診斷錯誤。干預的關鍵窗口期很短；未能及早檢測通常會導致生理狀況迅速惡化。此外，慢性共病的存在顯著提高了患嚴重登革熱的風險。根據 Anil Vardani 醫生的說法，糖尿病患者患登革出血熱的風險增加 2.5 倍，而若同時患有心血管疾病，該風險將增加 8 倍。高血壓和肥胖同樣與較高比例的血漿滲漏和器官功能障礙相關，而慢性腎臟病則與死亡率增加三倍相關。

Institutional efforts to mitigate these threats are currently focused on the implementation of rapid diagnostic testing (RDTs) and the strengthening of the '7-1-7' framework for outbreak detection and response. In Uganda, the SUPAAT project exemplifies a multi-sectoral approach involving enhanced surveillance and community engagement. However, a systemic deficit remains in the realm of therapeutics; there is currently no definitive antiviral treatment, and vaccine utility remains limited. The historical precedent of neglected tropical diseases suggests that research and development (R&D) funding often follows a crisis rather than preempting it, necessitating a shift toward sustained, cross-regional collaboration and integrated urban and environmental planning.

機構目前減輕這些威脅的重點在於實施快速診斷測試 (RDTs) 以及強化用於疫情偵測與應對的 「7-1-7」 框架。在烏干達，SUPAAT 計劃體現了一種涉及加強監控與社區參與的多部門協作方法。然而，治療領域仍存在系統性缺失；目前尚無決定性的抗病毒治療，且疫苗的效用仍然有限。被忽視熱帶疾病的歷史先例表明，研究與開發 (R&D) 資金往往是在危機發生後而非預先防範，因此有必要轉向持續的跨區域合作以及綜合城市與環境規劃。

Dengue remains a critical global health threat characterized by expanding transmission zones and high morbidity among vulnerable populations, requiring urgent investment in diagnostics and therapeutics.

登革熱仍然是一個關鍵的全球健康威脅，其特徵為傳播區域擴張以及易感人群中高發病率，需要緊急投資於診斷與治療。